Don't Put the Whole Programme on One Carrier: Insurer Panel Diversification as Risk Strategy in India 2026

Most corporate risk registers in India are thorough about the risks the company carries on its own balance sheet, the property that could burn, the supply chain that could break, the liability that could crystallise. They are far less thorough about a concentration the company creates the moment it buys insurance: the concentration of its claims-paying reliance on the insurers behind its programme. A company that places all of its property, liability and specialty cover with a single carrier has, in effect, made that carrier a single point of failure for its entire risk-transfer strategy, however financially strong the carrier appears today.

This is not a theoretical concern. The whole point of buying insurance is to convert an uncertain loss on the company's books into a certain recovery from a third party. That recovery is only as good as the third party. If the company has concentrated its programme with one insurer and that insurer is weakened, by an adverse run of catastrophe losses, a reserving shortfall, a rating downgrade or a wider market stress, the company has concentrated the risk that its recoveries do not arrive when it most needs them, which is precisely after a large loss when markets are stressed.

The Indian market gives this question fresh salience in 2026. The regulator continues to designate a small set of insurers as systemically important, reaffirming the largest life, general and reinsurance players in that category for the financial year and subjecting them to enhanced supervision and governance. The label is a useful reminder of something a risk manager should already internalise: insurers are not interchangeable, and the consequences of one failing or being stressed are not evenly distributed. At the same time, the transition to a risk-based capital regime is sharpening the differences between insurers in how robustly they are capitalised against what they actually write.

None of this means a buyer should distrust strong insurers or fragment its programme for its own sake. It means the buyer should make a conscious choice about how much of its claims-paying reliance sits with any one counterparty, weigh that against the convenience and pricing benefits of consolidation, and treat the resulting concentration as something to be managed rather than ignored.

Insurer concentration is rarely the result of a deliberate decision to bet the programme on one carrier. It builds up quietly, through a series of individually sensible choices, until a buyer looks up and finds that one insurer carries most of its risk. Understanding how that happens is the first step to managing it.

Several forces push toward consolidation:

• Pricing and convenience. A single insurer writing the whole programme can offer a package discount, a single point of contact, aligned renewal dates and simpler administration. Each renewal, the incumbent's bundled quote looks attractive against the friction of splitting the programme, so consolidation deepens.
• The incumbent advantage. An insurer that already holds the programme knows the risk, has the data and can quote quickly and competitively to retain it. Over successive renewals this tends to entrench the incumbent across more lines rather than fewer.
• Broker convenience. A broker managing a consolidated programme with one carrier has a simpler job than coordinating several. Without a buyer actively asking about diversification, the path of least resistance is consolidation.
• Group and parent arrangements. Multinationals placed through a global programme, or Indian groups with a preferred relationship, may default large parts of their cover to one carrier or its fronting partner for reasons of group policy rather than counterparty strategy.

None of these forces is wrong, and consolidation has genuine benefits: better pricing, simpler claims, a carrier that understands the account. The problem is that the counterparty-concentration cost of consolidation is invisible at the point each decision is made. No single renewal feels like a dangerous bet on one insurer; it is the accumulation that creates the exposure, and accumulation does not announce itself.

The corrective is to make concentration visible and deliberate. A buyer should be able to state, at any time, how its total claims-paying reliance is distributed across carriers: what share of its aggregate limits, and more importantly what share of its largest potential single recovery, sits with each insurer. Once that distribution is visible, the buyer can decide whether it is comfortable with it. The distribution might be perfectly acceptable, a strong, well-diversified, highly rated insurer carrying a large share may be a sound choice, but it should be a choice, made with the concentration in view, rather than a default arrived at by inertia.

Diversifying the insurer panel does not mean buying lots of small, fragmented policies. It means structuring significant placements so that the claims-paying reliance is spread across more than one strong carrier, using two well-established mechanisms: co-insurance and layered placement. Both let a buyer keep a coherent programme while distributing the counterparty risk.

Co-insurance is the sharing of a single risk among several insurers, each taking an agreed proportion of the same cover on the same terms. If three insurers co-insure a property programme in shares of, say, fifty, thirty and twenty per cent, a covered loss is borne by each in its proportion, and the buyer's recovery is spread across three balance sheets rather than concentrated on one. The buyer holds a single policy wording with a common set of terms, so co-insurance preserves consistency while diversifying the security. The lead insurer typically handles the relationship and claims, which keeps the administration manageable. The diversification benefit is direct: the failure or weakening of any one co-insurer puts only its proportion of recoveries at risk, not the whole.

Layered placement stacks cover in successive limits, with different insurers taking different layers of the same tower. A primary insurer might carry the first tranche of limit, with excess insurers sitting above for higher layers that respond only once the layer beneath is exhausted. Because each layer can be placed with a different carrier, a large programme naturally diversifies its counterparty exposure, and a buyer can deliberately place the higher, less-frequently-hit layers with very strong carriers while using the primary layer to manage cost. Layering is the standard way large liability and high-value property towers are built, and the diversification it provides is a feature worth using consciously rather than a by-product to ignore.

In practice the two are combined: a tower built in layers, with several layers themselves co-insured. The result is a programme whose total security is drawn from several balance sheets, so that no single carrier's stress threatens the whole recovery. The distinction worth holding in mind is between horizontal spread, sharing each layer across several co-insurers, and vertical spread, distributing the different layers of the tower across different carriers; a well-built programme uses both, so that the failure of any one carrier costs the buyer at most that carrier's share of one layer rather than a whole band of cover.

A related mechanism is signing down. When a placement is oversubscribed, with insurers offering to take more in aggregate than the limit required, the broker can sign each line down proportionately, which lets the buyer keep more carriers on the slip at smaller individual shares and so diversify the security further without buying more cover than it needs. For very large or hard-to-place programmes, a buyer may also use a fronting arrangement, where a licensed insurer issues the policy and passes most of the risk on, or a captive to retain a layer deliberately; both change where the ultimate claims-paying reliance sits and should be understood as part of the concentration picture rather than ignored as plumbing.

There are trade-offs to manage:

1. Consistency of terms. Spreading a risk across carriers is only safe if they are on genuinely common terms; a mismatch in wording between co-insurers or between layers can leave a gap exactly where a claim falls. The terms must be aligned, which is a discipline in itself.
2. Claims coordination. More carriers can mean more parties to a large claim. A well-run co-insurance has a lead handling the claim on agreed terms, and a well-built tower has clear rules for how layers respond, so the buyer is not negotiating with several insurers at once.
3. Cost and effort. Diversification can cost a little more than full consolidation and takes more arranging. That cost is the price of resilience, and for a programme where a large recovery matters, it is usually worth paying.

The craft is to diversify the security without fragmenting the cover, so the buyer gains resilience while keeping a coherent, consistently worded programme.

Diversification of the insurer panel should not be an occasional reaction to a scare; it should be a governed part of how the company designs its risk-financing strategy, revisited at each renewal and visible to the board. The aim is a deliberate, documented position on how much counterparty concentration the company will accept, applied consistently across the programme.

A practical framework has four elements.

Set a concentration appetite. Just as a company sets a risk appetite for the exposures it retains, it can set a view on how much of its claims-paying reliance it is willing to place with any one carrier, scaled to the carrier's strength. A very strong, well-diversified, highly rated insurer might be allowed a larger share than a weaker one. The point is to have an explicit standard rather than discovering the concentration after the fact.

Weight by what matters: the largest single recovery. Concentration is best measured not by premium split but by where the largest single potential recovery sits, because that is the recovery whose failure would hurt most. A buyer should know which carrier stands behind its biggest exposures and whether that reliance is within its appetite.

Use diversification where the reliance is greatest, consolidation where it is not. Not every cover needs spreading. Small, short-tail covers where any claim is paid quickly can sit with one carrier for simplicity. The diversification effort should concentrate on the high-limit, long-tail and catastrophe-exposed covers where the buyer is most reliant on the carrier being strong when the claim falls due, and where co-insurance and layering are the natural tools.

Watch for hidden correlation between your carriers. Spreading a programme across several insurers only diversifies the security if those insurers would not weaken together. If two co-insurers on your property tower both depend heavily on the same reinsurer, or both carry concentrated exposure to the same flood basin or seismic zone, a single catastrophe could stress both at once, so the apparent diversification is thinner than the carrier count suggests. The same logic applies to a market-wide event: if several of your carriers are exposed to the same systemic shock, a correlated downgrade can hit your panel together. True diversification looks past the number of names to whether their fortunes are genuinely independent.

Document the decision and refresh it. Record why the programme is structured as it is, what concentration the company is accepting and why, and revisit it at each renewal as carriers' strength and the buyer's exposures change. This turns diversification from an ad hoc choice into a governed control the board can see.

The broader context makes this timely. The regulator continues to designate a small set of the largest life, general and reinsurance players as systemically important and to subject them to enhanced supervision, a reminder that insurers are not interchangeable and that the consequences of one being stressed are not evenly spread. A buyer might reasonably weight such a carrier as a sounder home for a large share, but should also recognise that if the whole market leans on the same handful of systemically important balance sheets, panel diversification at the individual-buyer level has limits. With the risk-based capital transition sharpening the differences between carriers, 2026 is a good moment for Indian corporates to look at their programmes through a concentration lens and decide, consciously, how much of their risk-transfer strategy should depend on any one balance sheet and on the reinsurance standing behind it.

This kind of analysis depends on being able to compare carriers and their wordings side by side and track how a programme is distributed across them. Sarvada gives commercial-insurance brokers and corporate risk teams structured, searchable access to insurer wordings and the intelligence around them, so the work of structuring a diversified, consistently worded programme across several carriers can be done rigorously rather than from memory. Risk teams and brokers designing resilient, well-diversified programmes can Request Access to evaluate the platform for programme design and renewal.